Escitalopram Treatment Guidelines for Major Depressive Disorder
Clinical Monitoring and Response Assessment
- The American College of Physicians recommends beginning monitoring within 1-2 weeks of initiation for therapeutic response, adverse effects, and emergence of suicidal ideation, as the risk for suicide attempts is greatest during the first 1-2 months of treatment 1, 2, 3
- Patients should be monitored for agitation, irritability, or unusual behavioral changes indicating worsening depression 1, 2, 3
Treatment Response Timeline
- Escitalopram separates from placebo by week 1, demonstrating rapid onset 4
- Assess adequacy of response at 6-8 weeks; modify treatment if inadequate response, as response rates to antidepressant therapy may be as low as 50% 1, 2, 3
Maintenance Treatment Duration
- The American College of Physicians recommends continuing treatment for 4-9 months after satisfactory response to prevent relapse 1, 2, 3
- Patients achieving remission during acute treatment should continue therapy to prevent relapse 1, 2, 3
- Consider years to lifelong maintenance therapy for patients with recurrent MDD (≥2 episodes) 1, 2, 3
Discontinuation Protocol
- Discontinuation symptoms include dizziness, fatigue, nausea, insomnia, and sensory disturbances 5